Necrotizing infundibular crystalline folliculitis manifesting as a perforating mucinosis: a case report.

: Necrotizing infundibular crystalline folliculitis (NICF) is a rare entity manifesting as waxy folliculocentric papules comprised of filamentous birefringent crystalline deposits. We report a case of NICF in an 85-year-old man, presenting as gritty, cream-colored, and erythematous papules across the midline back. Biopsy demonstrated a pale plug comprised of copious mucin.

Progressive multifocal leukoencephalopathy in two psoriasis patients treated with efalizumab.

Progressive multifocal leukoencephalopathy (PML) is a rare neurological disorder that occurs almost exclusively in immunocompromised individuals by reactivation of the John Cunningham virus (JC virus), a polyomavirus found latent in more than 80 percent of healthy adults. Efalizumab, an immunosuppressive monoclonal antibody targeting T cells, has been used for treatment of moderate-to-severe chronic psoriasis. The authors describe two cases of PML that occurred in patients < or = 70 years old treated with efalizumab for more than three years.

Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding.

Hand-foot syndrome is a common adverse effect of therapy with capecitabine (Xeloda) for the treatment of various carcinomas. Symptoms suggesting hand-foot syndrome include pain, pruritus, erythema, tingling and desquamation limited to the palms and soles of feet. Documented pathological findings are few, but include apoptosis of keratinocytes, bizarre mitotic figures, loss of polarity of keratinocytes and vacuolar degeneration of the basal layer of the epidermis.

Granulomatous slack skin without evidence of a clonal T-cell proliferation.

Granulomatous slack skin is a rare cutaneous disorder with less than 50 cases presented in the English-language literature. The disease is characterized by circumscribed erythematous lax skin accentuated most commonly in the axillary and inguinal areas. A strong association with a preceding or evolving diagnosis of mycosis fungoides or Hodgkin's disease has been reported.

Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis.

Background: Tacrolimus is a macrolactam that prevents the transcription of messenger RNA for various inflammatory cytokines in both helper T cells (types 1 and 2) (T(H)1 and T(H)2). It is currently approved for the treatment of moderate to severe atopic dermatitis, a Th2-mediated disease, in children and adults.

Objective: We sought to evaluate the safety and efficacy of tacrolimus ointment 0.